Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest.

Choi, Seung-Hye; Kim, Sung Eun; Lim, Hyun Hye; Lee, Dong-Yun; Choi, DooSeok

Choi, Seung-Hye; Kim, Sung Eun; Lim, Hyun Hye; Lee, Dong-Yun; Choi, DooSeok.

Afiliação

Lim HH; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee DY; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Choi D; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. dooseok.choi@samsung.com.

J Korean Med Sci ; 37(26): e207, 2022 07 04.

Article em En | MEDLINE | ID: mdl-35790209

Assuntos

Endometriose; Anticoncepção; Anticoncepcionais Orais/uso terapêutico; Endometriose/tratamento farmacológico; Endometriose/prevenção & controle; Endometriose/cirurgia; Feminino; Hormônio Liberador de Gonadotropina/uso terapêutico; Humanos; Nandrolona/análogos & derivados; Estudos Retrospectivos; Prevenção Secundária/métodos

Palavras-chave

Dienogest; Endometrioma; Endometrioma Recurrence; Endometriosis; Oral Contraceptive

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endometriose Tipo de estudo: Observational_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google